Abstract:Human milk (HM) is rich in microRNAs that support neurodevelopment of newborns. Low HM miR‐146a content may contribute to autism spectrum disorder (ASD) onset among breastfed offspring. Overabundance of miR‐106a may increase the severity of autistic symptoms. Therefore, maternal health care maintains optimal breastmilk miRNome and can reduce risk of ASD. Autism spectrum disorder (ASD) is a set of neurobehavioral manifestations that impose poor social interaction and stereotyped repetitive patterns. Several mircoRNA (miRNA) dysregulations underpin ASD pathophysiology via impairing the neurogenic niches. For instance, miR‐146a and miR‐106 differential expressions are linked to deregulation of ASD‐related genes and the severity of clinical symptoms, respectively. Breastfeeding provides newborns with many bioactive compounds that support their neurodevelopment including miRNA. Our pilot study evaluated the expression pattern of miR‐106a and miR‐146a in human milk (HM) of nursing mothers (n = 36) having autistic children compared to age‐matched counterparts (n = 36) with neurotypical children as controls. Under sterile conditions, breast milk samples were collected using manual sucking pumps and centrifuged to separate the fat layer. Total RNA was extracted from the lipid fraction, and the expression profiles of both miR‐106a and miR‐146a were evaluated using quantitative real‐time polymerase chain reaction. Among the test group, we reported some factors that were previously linked to HM miRNA perturbations: gestational diabetes, hypertension, and cesarean delivery. HM miR‐106a showed comparable expression levels in both mother groups (p = 0.8681), whereas HM miR‐146a was significantly downregulated in mothers with autistic children compared to controls (p = 0.0399). Alternatively, HM miR‐106 levels were positively associated with two ASD clinical parameters: Childhood Autism Rating Scale (CARS) and communication and language domain of Autism Diagnostic Interview‐Revised (ADI‐R) (r = 0.6452, p = 0.0003 and r = 0.3958, p = 0.0410, respectively). The receiver operating characteristic (ROC) curves of both maternal HM miR‐106a and miR‐146a showed poor fitness as predictive biomarkers for ASD. Our findings suggest that the miR‐146a differential expression in ASD children may originate at infancy during the lactation period. Thus, maternal pre‐ and postnatal health care is critical to maintain optimal miRNome in breast milk.

Serum microRNA profiles in children with autism

miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis

Autism spectrum disorder: difficulties in diagnosis and microRNA biomarkers

Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder

A heritable profile of six miRNAs in autistic patients and mouse models

Alterations in the MicroRNA of the Blood of Autism Spectrum Disorder Patients: Effects on Epigenetic Regulation and Potential Biomarkers

Whole-transcriptome Analysis of Serum Neuron-Derived Exosomes Reveals Specific Signature for Autism Spectrum Disorder in Chinese Children

MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder

MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research

Heterogeneous dysregulation of microRNAs across the autism spectrum

Peptidome Analysis Reveals Novel Serum Biomarkers for Children with Autism Spectrum Disorder in China.

Serum cytokine levels in children with spectrum autism disorder: Differences in pro- and anti-inflammatory balance

Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects.

Atypical miRNA expression in temporal cortex associated with dysregulation of immune, cell cycle, and other pathways in autism spectrum disorders

Whole-Transcriptome Analysis of Serum L1CAM-Captured Extracellular Vesicles Reveals Neural and Glycosylation Changes in Autism Spectrum Disorder

Dysregulation of miR‐146a in human milk of mothers having children with autism

Exploratory Analysis of MicroRNA Alterations in a Neurodevelopmental Mouse Model for Autism Spectrum Disorder and Schizophrenia

Mirna Profiling in Autism Spectrum Disorder in China.

Proteomics Study of Peripheral Blood Mononuclear Cells (PBMCs) in Autistic Children

Serum Glycopattern and Maackia Amurensis Lectin-Ii Binding Glycoproteins in Autism Spectrum Disorder

Investigation of Gene Regulatory Networks Associated with Autism Spectrum Disorder Based on MiRNA Expression in China